1-20 of 95
Abraham Avigdor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Available to Purchase
Kai Rejeski, Jaime Sanz, Teng Fei, Monica S Nair, Hamza Hashmi, Abraham Avigdor, Ofrat Beyar-Katz, Veit L. Bücklein, Kevin J. Curran, Sigrun Einarsdottir, Jonathan H Esensten, Netta Glaubach, Dr, Noa Golan-Accav, Marina Gomez-Llobell, Iris Halamis, Orit Itzhaki, Frederick L. Locke, Sham Mailankody, Ronit Marcus, Marcela V. Maus, M. Lia Palomba, Jae H Park, Marcelo C. Pasquini, Sandeep S Raj, Sridevi Rajeeve, Gilles A. Salles, Michael Scordo, Gunjan L Shah, Avichai Shimoni, Marion Subklewe, Tobias Tix, Saad Z Usmani, Ori Ben Valid, Yannis K. Valtis, Tsila Zuckerman, Nirali N Shah, Miguel-Angel Perales, Roni Shouval
Journal: Blood
Blood blood.2025028833.
https://doi.org/10.1182/blood.2025028833
Published: 2025
Includes: Supplemental data
Journal Articles

CAR-Tography: Longitudinal Mapping of CAR-T Toxicities across B-Cell Malignancies Reveals Biologically Distinct and Prognostically Relevant Toxicity Phenotypes

Free
Kai Rejeski, Teng Fei, Alejandro Luna, Mohammad Alhomoud, Yannis K. Valtis, Noriko Nishimura, Marina Gomez-Llobell, Noa Golan Accav, Ofrat Beyar-Katz, Sandeep S. Raj, Magdalena Corona, Alfredo Rivas-Delgado, Hamza Hashmi, Sridevi Rajeeve, Efrat Luttwak, Michael Scordo, Gunjan L. Shah, Maria Lia Palomba, Michael von Bergwelt-Baildon, Marion Subklewe, Abraham Avigdor, Ronit Marcus, Avichai Shimoni, Arnon Nagler, Tsila Zuckerman, Jabour Halloun, Uri Greenbaum, Sham Mailankody, Saad Z. Usmani, Gilles Salles, Jae H. Park, Miguel Angel Perales, Roni Shouval
Journal: Blood
Blood (2024) 144 (Supplement 1): 912.
https://doi.org/10.1182/blood-2024-203520
Published: 2024
Journal Articles

Tumor Determinants of Response to CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma

Free
Zachary D. Epstein-Peterson, Christine E. Ryan, Sean M. Devlin, Noa Golan Accav, Abraham Avigdor, Magdalena Corona, Ivetta Danylesko, Jamie Dela Cruz, Andre Goy, Caron A. Jacobson, Ofrat Beyar Katz, Hazim Khatib, Anita Kumar, Lori A. Leslie, Alejandro Luna, Ronit Marcus, Reid W. Merryman, Miguel Angel Perales, Alfredo Rivas-Delgado, Gilles Salles, Michael Scordo, Inbal Sdayoor, Gunjan L. Shah, Noga Shem-Tov, Avichai Shimoni, Nataly Vahaba, Ronit Yerushalmi, Andrew D. Zelenetz, Maria Lia Palomba, Andrew Ip, Roni Shouval
Journal: Blood
Blood (2024) 144 (Supplement 1): 4393.
https://doi.org/10.1182/blood-2024-193091
Published: 2024
Journal Articles

Immune Biomarkers of Mechanism of Action of Epcoritamab (Epcor) Plus Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) in Frontline DLBCL

Free
Neha Dixit, Binhuan Wang, Kevin Zhao, Catherine Thieblemont, Irit Avivi Mazza, David Lavie, Abraham Avigdor, Carlos Grande Garcia, Andrew J. Steele, Mostafa Seliem, Pegah Jafarinasabian, Edith Szafer Glusman
Journal: Blood
Blood (2024) 144 (Supplement 1): 1734.
https://doi.org/10.1182/blood-2024-200395
Published: 2024
Journal Articles

Comparable Outcomes of Point-of-Care and Commercial CD19 CAR-T Therapies: A Patient-Matched Analysis in Large B-Cell Lymphoma

Free
Ronit Marcus, Abraham Avigdor, Uri Greenbaum, Noa Golan Accav, Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Elad Jacoby, Arnon Nagler, Avichai Shimoni, Annamaria Ballweg, Xavier Deschênes-Simard, Efrat Luttwak, Gunjan L. Shah, Michael Scordo, Parastoo B Dahi, Miguel Angel Perales, Tsila Zuckerman, Israel Henig, Dana Yehudai-Ofir, Hazim Khatib, Roni Shouval, Ofrat Beyar Katz
Journal: Blood
Blood (2024) 144 (Supplement 1): 608.
https://doi.org/10.1182/blood-2024-207638
Published: 2024
Journal Articles

When Can We Define Cure after CAR-T Therapy in LBCL? Insights from Serial Landmark Analyses

Free
Marina Gomez-Llobell, Roni Shouval, Samantha Brown, Noa Golan Accav, Sean M. Devlin, Magdalena Corona, Kai Rejeski, Alfredo Rivas-Delgado, Alejandro Luna, Efrat Luttwak, Sandeep S. Raj, Mohammad Alhomoud, Ronit Marcus, Avichai Shimoni, Shimrit Ringelstein-Harlev, Alexander P. Boardman, Parastoo B Dahi, Richard J. Lin, Michael Scordo, Lorenzo Falchi, Gunjan L. Shah, Maria Lia Palomba, Gilles Salles, Jae H. Park, Ofrat Beyar-Katz, Abraham Avigdor, Miguel Angel Perales
Journal: Blood
Blood (2024) 144 (Supplement 1): 2369.
https://doi.org/10.1182/blood-2024-201029
Published: 2024
Journal Articles

Comparative Real-World Outcomes of Commercial CD19-Directed CAR T-Cell Therapies in Large B-Cell Lymphoma

Free
Xavier Deschênes-Simard, Maria Bromberg, Sean M. Devlin, Ofrat Beyar Katz, Andrew Ip, Ronit Marcus, Abraham Avigdor, Annamaria Ballweg, Emma Rabinovich, Mohammad Alhomoud, Alfredo Rivas-Delgado, Magdalena Corona, Alejandro Luna De Abia, Maria Lia Palomba, Gunjan L. Shah, Richard J. Lin, Alexander P. Boardman, Lorenzo Falchi, Jennifer Kimberly Lue, Gilles Salles, Miguel-Angel Perales, Roni Shouval, Parastoo B Dahi, Michael Scordo
Journal: Blood
Blood (2024) 144 (Supplement 1): 3752.
https://doi.org/10.1182/blood-2024-211475
Published: 2024
Journal Articles

Impact of Broad-Spectrum Antibiotic Exposure on CAR-T Therapy Outcomes in B-Cell Lymphoma: A Multicenter International Study

Free
Roni Shouval, Teng Fei, Giulia Gabrielli, Natalie Grier Smith, Guido Ghilardi, John Slingerland, Jonathan U. Peled, Ying Taur, Sunita D. Nasta, Alejandro Luna, Magdalena Corona, Kai Rejeski, Sophia Stock, Ronit Marcus, Noa Golan Accav, Ofrat Beyar-Katz, Hazim Khatib, Sandeep S. Raj, Alexander P. Boardman, Parastoo B Dahi, Richard J. Lin, Michael Scordo, Lorenzo Falchi, Jakub Svoboda, Elise A. Chong, Stefan K. Barta, Daniel J. Landsburg, Avichai Shimoni, Arnon Nagler, Gunjan L. Shah, Maria Lia Palomba, Gilles Salles, Jae H. Park, Stephen J. Schuster, Tsila Zuckerman, Marion Subklewe, Abraham Avigdor, Miguel Angel Perales, Marcel R.M. van den Brink, Marco Ruella
Journal: Blood
Blood (2024) 144 (Supplement 1): 1746.
https://doi.org/10.1182/blood-2024-203871
Published: 2024
Journal Articles

Glofitamab in Combination with Polatuzumab Vedotin Maintains Durable Responses and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Including High-Grade B-Cell Lymphoma (HGBCL): Extended Follow-up of a Phase Ib/II Study

Free
Martin Hutchings, Anna Sureda Balari, Francesc Bosch, Thomas Stauffer Larsen, Paolo Corradini, Abraham Avigdor, María José Terol, Antonio Rueda Dominguez, Antonio Pinto, Alan P Skarbnik, Raul Cordoba, Judit Mészáros Joergensen, Pier Luigi Zinzani, Ronit Gurion, Neta Goldschmidt, Wilfred Leung, Donghang Li, James Relf, Maneesh Tandon, Gila Sellam, Giuseppe Gritti
Journal: Blood
Blood (2024) 144 (Supplement 1): 988.
https://doi.org/10.1182/blood-2024-194328
Published: 2024
Journal Articles

Fixed-Duration Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results from Arm 1 of the Epcore NHL-5 Trial

Free
Ronit Gurion, Irit Avivi Mazza, Catherine Thieblemont, Won Seog Kim, Andras Masszi, Alejandro Martín García-Sancho, Zsolt Nagy, Benoit Tessoulin, Ana Jimenez Ubieto, Po-Shen Ko, Daniel Alan Kerr, II, Edwin E. Jeng, Satya Siddani, Neha Joshi, Neha Dixit, Mariana Sacchi, Pegah Jafarinasabian, Abraham Avigdor
Journal: Blood
Blood (2024) 144 (Supplement 1): 3110.
https://doi.org/10.1182/blood-2024-199301
Published: 2024
Journal Articles

CD19 CAR-T Cell Therapy Is Effective in Richter Transformation: A Multicenter Retrospective Analysis By the European Research Initiative on Chronic Lymphocytic Leukemia

Free
Ofrat Beyar-Katz, Ohad Benjamini, Julio Delgado, Marco Ruella, Ron Ram, Sigal Grisariu, Andrea Visentin, Elisabeth Vandenberghe, Massimo Gentile, Abraham Avigdor, Avichai Shimoni, Roni Shouval, Ronit Marcus, Stephen J. Schuster, Valentin Ortiz-Maldonado, Guido Ghilardi, Luca Paruzzo, Tsila Zuckerman, Tamar Tadmor, Riva Fineman, Odelia Amit, Nuria Martinez-Cibrian, Giulia Gabrielli, Batia Avni, Eva Minga, Noga Shem-Tov, Lydia Scarfo, Ronit Yerushalmi, Arnon Nagler, Ronit Leiba, Ivetta Danylesko, Kostas Stamatopoulos, Thomas Chatzikonstantinou, Paolo Ghia, Yair Herishanu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4504.
https://doi.org/10.1182/blood-2024-200050
Published: 2024
Journal Articles

Epcoritamab for Relapsed/Refractory B Cell Lymphoma - the Israeli Real-World Experience of a Compassionate Use Program

Free
Shlomzion Aumann, Abraham Avigdor, Ronit Marcus, Netanel A. Horowitz, Ronit Gurion, Tamar Tadmor, Roy Vitkon, May Meira Basood, Uri Abadi, Meirav Kedmi
Journal: Blood
Blood (2024) 144 (Supplement 1): 5124.
https://doi.org/10.1182/blood-2024-198926
Published: 2024
Journal Articles

The Impact of Cardiovascular Vulnerabilities in Non Hodgkin Lymphoma Patients Treated with Chimeric Antigen Receptor T Cell Therapy

Free
Ivan Landego, Jessica R Flynn, Adam Goldman, Sean M. Devlin, Efrat Luttwak, Alejandro Luna De Abia, Magdalena Corona, Meirav Kedmi, Inbal Sdayoor, Shalev Fried, Noga Shem-Tov, Avichai Shimoni, Ivetta Danylesko, Mohammad Hammoud, Ronit Yerushalmi, Arnon Nagler, Ronit Marcus, Ahmed El-Moghraby, Mahin Rehman, Parastoo B. Dahi, Sergio A. Giralt, Richard J. Lin, Maria Lia Palomba, Michael Scordo, Gunjan L. Shah, Miguel-Angel Perales, Syed Mahmood, Abraham Avigdor, Jennifer Liu, Roni Shouval
Journal: Blood
Blood (2023) 142 (Supplement 1): 6908.
https://doi.org/10.1182/blood-2023-187338
Published: 2023
Journal Articles

Favezelimab (anti-LAG-3) Plus Pembrolizumab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Cohort 3 of a Multicohort Open-Label Phase 1/2 Study

Free
Armando Santoro, Nathalie A. Johnson, Kerry J. Savage, Abraham Avigdor, Ali Bazargan, Peter Borchmann, Robin Gasiorowski, Gareth P. Gregory, Yair Herishanu, Sumit Madan, Leonard Minuk, Gerardo Musuraca, Rachel Marceau West, Pallavi Pillai, Patricia Marinello, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 1725.
https://doi.org/10.1182/blood-2023-182536
Published: 2023
Journal Articles

Pre-Treatment Pulmonary Assessment Have Limited Utility in B-Cell Lymphoma Patients Treated with Autologous Anti-CD19 CAR T-Cell Therapy

Free
Inbal Sdayoor, Roni Shouval, Shalev Fried, Ronit Marcus, Ivetta Danylesko, Ronit Yerushalmi, Noga Shem-Tov, Orit Itzhaki, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Avichai Shimoni, Michael J Segel, Abraham Avigdor
Journal: Blood
Blood (2023) 142 (Supplement 1): 3519.
https://doi.org/10.1182/blood-2023-180115
Published: 2023
Journal Articles

Efficacy and Safety of Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Free
Ranjana H. Advani, Abraham Avigdor, Anna Maria Sureda Balari, David Lavie, Stefan Hohaus, Jan M. Zaucha, Vu Minh Hua, Vittorio Ruggero Zilioli, Raimundo Gazitua, Muhit Ozcan, Amos Odeleye-Ajakaye, Nishitha Reddy, Patricia Marinello, Jane N. Winter
Journal: Blood
Blood (2023) 142 (Supplement 1): 3068.
https://doi.org/10.1182/blood-2023-181171
Published: 2023
Journal Articles

R-GemOx Plus Nivolumab Vs R-GemOx As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Interim Analysis of the Niveau Trial, an International, Randomized Phase 3 Study of the AGMT, GLA, HOVON, Lysa and PLRG

Free
Gerhard Held, Bettina Altmann, Andrea Kerkhoff, Thomas Gastinne, Thomas Weber, Rene-Olivier Casasnovas, Hervé Tilly, Maria Gomes Da Silva, Jörg Hoffmann, Sanne Tonino, Stéphane Vigouroux, Martin Dreyling, Violaine Safar, Marc Andre, Stephanie Mayer, Franck Morschhauser, Pierre Feugier, Christian W. Scholz, Anna Dabrowska-Iwanicka, Philippe Gaulard, Thierry Jo Molina, Andreas Rosenwald, Richard Greil, Ulrich Jaeger, Abraham Avigdor, Lorenz Thurner, Stephanie Maurer, Markus Löffler, Marita Ziepert, Corinne Haioun, Viola Poeschel, Roch Houot
Journal: Blood
Blood (2023) 142 (Supplement 1): 435.
https://doi.org/10.1182/blood-2023-172951
Published: 2023
Journal Articles

High Response Rates Following Point-of-Care Anti-CD19 CAR T-Cell Therapy in Adults with Relapsed/Refractory Acute B Lymphoblastic Leukemia

Free
Shalev Fried, Ivetta Danylesko, Ronit Marcus, Orit Itzhaki, Ronit Yerushalmi, Noga Shem-Tov, Inbal Sdayoor, Roni Shouval, Elad Jacoby, Meirav Kedmi, Arnon Nagler, Avichai Shimoni, Abraham Avigdor
Journal: Blood
Blood (2023) 142 (Supplement 1): 6875.
https://doi.org/10.1182/blood-2023-178477
Published: 2023
Journal Articles

Glofitamab Plus Polatuzumab Vedotin Continues to Demonstrate Frequent and Durable Responses and Has a Manageable Safety Profile in Patients with ≥2L Relapsed/Refractory DLBCL, Including HGBCL, and in Patients with Prior CAR T-Cell Therapy: Updated Results from a Phase Ib/II Study

Free
Martin Hutchings, Abraham Avigdor, Anna Maria Sureda Balari, Maria José Terol, Francesc Bosch, Paolo Corradini, Thomas S. Larsen, Antonio Rueda Dominguez, Alan Skarbnik, Judit Mészáros Joergensen, David Lavie, Ronit Gurion, Pier Luigi Zinzani, Antonio Pinto, Raul Cordoba, Alessia Bottos, Donghang Li, James Relf, Audrey Filézac De L'Étang, Gila Sellam, Giuseppe Gritti
Journal: Blood
Blood (2023) 142 (Supplement 1): 4460.
https://doi.org/10.1182/blood-2023-174213
Published: 2023
Journal Articles

Bisantrene in Combination with Fludarabine and Clofarabine As Salvage Therapy for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)- an Open-Label, Phase II, Study

Free
Ivetta Danylesko, Avichai Shimoni, Abraham Avigdor, Meirav Kedmi, Noga Shem-Tov, Ronit Yerushalmi, Maya Sasson, Dan Dominissini, Borje S. Andersson, Arnon Nagler
Journal: Blood
Blood (2023) 142 (Supplement 1): 4292.
https://doi.org/10.1182/blood-2023-178286
Published: 2023